Indian homegrown private equity (PE) major ChrysCapital is close to investing $100 million in Gujarat-based drug manufacturer Corona Remedies to help the latter fund its organic and inorganic expansion plans, DealStreetAsia has learnt.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
